epigallocatechin gallate has been researched along with Epithelial Ovarian Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bairati, I; Bazinet, L; Fradet, V; Labbé, DP; Têtu, B; Trudel, D | 1 |
| Beale, P; Chan, C; Huq, F; Mazumder, ME; Yu, JQ | 1 |
1 review(s) available for epigallocatechin gallate and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies.
Topics: Animals; Apoptosis; Carcinoma, Ovarian Epithelial; Catechin; Cell Line, Tumor; Cell Movement; Female; Humans; Incidence; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Protective Agents; Tea | 2012 |
1 other study(ies) available for epigallocatechin gallate and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; DNA Adducts; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Palladium | 2012 |